(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TERS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TERS

ST13

US500000087391827

Class

1, 5, 42, 44

Filing

87391827

Registration

5991518

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

49

Latest update

04/23/2026

Trademark type

Word

Nice classes

1, 5, 42, 44

Filing date

03/30/2017

Registration date

02/18/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/18/2020

Last transaction

04/23/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

First use anywhere

06/16/2017

First use in commerce

08/14/2017

Drawing code

4

Owner type

99

Owner location

Berlin, DE

Examiner

BUTLER, MIDGE

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

JPT Peptide Technologies GmbH

Representatives

Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.

Technical classification

Nice Classes

Class 1Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

(Based on 44(e)) (Based on Use in Commerce) Nucleic acidsin particular RNA for use as reference standards in science and industry; control agentscertified samples of nucleic acids; TCR-engineered reference samples; reagents for use as transfectioncontrol and standardization agents

Class 5

(Based on 44(e)) (Based on Use in Commerce) Preparations and diagnostic test kits comprising nucleic acidssolventsprinted instructions for clinical or medical laboratory usein particular for use in analysis of gene expressionin particular analysis of engineered blood cells and for use in determining the progression of diseasesfor use in determining drug and therapeutic responses; diagnostic laboratory reagents for use as transfectioncontrol and standardization reagents

Class 42

(Based on 44(e)) Scientific and industrial research and development in the field of biochemistry and immunology; research and development of reference materialsin particular nucleic acids for use as reference standards in scientific and industrial laboratories; Clinical or medical laboratory services; gene expression and blood cell testing to determine immune responsedetection of diseasesprogression of diseasesresponse to treatments; cultivation and purification of cellsin particular of body cells and cells of the immune system of mammals including human cells

Class 44

(Based on 44(e)) Clinical and medical diagnostic services

Publications

History of USPTO decisions and trademark events.

49 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/22/2026

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

04/22/2026

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

04/22/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/22/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/22/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/22/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/22/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/18/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/18/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/16/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/15/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/09/2020

IUAF

USE AMENDMENT FILED

01/02/2020

EISU

TEAS STATEMENT OF USE RECEIVED

01/02/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/18/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/18/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/03/2019

EX1G

SOU EXTENSION 1 GRANTED

10/01/2019

EXT1

SOU EXTENSION 1 FILED

10/01/2019

EEXT

SOU TEAS EXTENSION RECEIVED

10/01/2019

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

09/27/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/25/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/25/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/02/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/05/2019

PUBO

PUBLISHED FOR OPPOSITION

02/05/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/16/2019

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

12/28/2018

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

12/21/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/14/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/13/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/13/2018

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

12/11/2018

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

06/12/2018

GNSI

INQUIRY TO SUSPENSION E-MAILED

06/12/2018

CNSI

SUSPENSION INQUIRY WRITTEN

06/12/2018

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

12/12/2017

GNSL

LETTER OF SUSPENSION E-MAILED

12/12/2017

CNSL

SUSPENSION LETTER WRITTEN

12/12/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/08/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/08/2017

ALIE

ASSIGNED TO LIE

12/05/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/27/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/22/2017

GNRT

NON-FINAL ACTION E-MAILED

06/22/2017

CNRT

NON-FINAL ACTION WRITTEN

06/22/2017

DOCK

ASSIGNED TO EXAMINER

06/22/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/05/2017

NWAP

NEW APPLICATION ENTERED

04/03/2017

Continuous trademark protection

Get notified about every new filing that threatens TERS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.